Библиография

1. 1. Perry S. V. Vertebrate tropomyosin: distribution, properties and function. J. Muscle Res. Cell Motil., 22, 5–49 (2001).
2. 2. Nevzorov I. A. and Levitsky D. I. Tropomyosin: double helix from the protein world. Biochemistry (Moscow), 76 (13), 1507–1527 (2011). DOI: 10.1134/S0006297911130098
3. 3. Redwood C. and Robinson P. Alpha-tropomyosin mutations in inherited cardiomyopathies. J. Muscle Res. Cell Motil., 34, 285–294 (2013). DOI: 10.1007/s10974-013-9358-5
4. 4. Moraczewska J. Thin filament dysfunctions caused by mutations in tropomyosin Tpm3.12 and Tpm1.1. J. Muscle Res. Cell Motil., 41, 39–53 (2020). DOI: 10.1007/s10974-019-09532-y
5. 5. Matyushenko A. M. and Levitsky D. I. Molecular mechanisms of pathologies of skeletal and cardiac muscles caused by point mutations in the tropomyosin genes. Biochemistry (Moscow), 85 (Suppl. 1), S20–S33 (2020). DOI: 10.1134/S0006297920140023
6. 6. Man Y., Yi C., Fan M., Yang T., Liu P., Liu S., and Wang G. Identification of a novel missense mutation in the TPM1 gene via exome sequencing in a Chinese family with dilated cardiomyopathy: a case report and literature review. Medicine, 101, e28551 (2022). DOI: 10.1097/MD.0000000000028551
7. 7. Bing W., Knott A., Redwood C., Esposito G., Purcell I., Watkins H., and Marston S. Effect of hypertrophic cardiomyopathy mutations in human cardiac muscle α-tropomyosin (Asp175Asn and Glu180Gly) on the regulatory properties of human cardiac troponin determined by in vitro motility assay. J. Mol. Cell. Cardiol., 32 (8), 1489−1498 (2000). DOI:10.1006/jmcc.2000.1182
8. 8. Golitsina N., An Y., Greenfield N. J., Thierfelder L., Iizuka K., Seidman J. G., Seidman C. E., Lehrer S. S., and Hitchcock-DeGregori S. E. Effects of two familial hypertrophic cardiomyopathy-causing mutations on α-tropomyosin structure and function. Biochemistry, 36 (15), 4637−4642 (1997). DOI: 10.1021/bi962970y
9. 9. Kremneva E., Boussouf S., Nikolaeva O., Maytum R., Geeves M. A., and Levitsky D. I. Effects of two familial hypertrophic cardiomyopathy mutations in α-tropomyosin, Asp175Asn and Glu180Gly, on the thermal unfolding of actin-bound tropomyosin. Biophys. J., 87, 3922−3933 (2004). DOI: 10.1529/biophysj.104.048793
10. 10. Li X. E., Suphamungmee W., Janco M., Geeves M. A., Marston S. B., Fischer S., and Lehman W. The flexibility of two tropomyosin mutants, D175N and E180G, that cause hypertrophic cardiomyopathy. Biochem. Biophys. Res. Commun., 424, 493−496 (2012). DOI: 10.1016/j.bbrc.2012.06.141
11. 11. Kopylova G. V., Shchepkin D. V., Nabiev S. R., Matyushenko A. M., Koubassova N. A., Levitsky D. I., and Bershitsky S. Y. Cardiomyopathy-associated mutations in tropomyosin differently affect actin-myosin interaction at single-molecule and ensemble levels. J. Muscle Res. Cell Motil., 40, 299–308 (2019). DOI: 10.1007/s10974-019-09560-8
12. 12. Matyushenko A. M., Shchepkin D. V., Kopylova G. V., Popruga K. E., Artemova N. V., Pivovarova A. V., Bershitsky S. Y., and Levitsky D. I. Structural and functional effects of cardiomyopathy-causing mutations in troponin T-binding region of cardiac tropomyosin. Biochemistry, 56, 250–259 (2017). DOI: 10.1021/acs.biochem.6b00994
13. 13. Matyushenko A. M., Koubassova N. A., Shchepkin D. V., Kopylova G. V., Nabiev S. R., Nikitina L. V., Bershitsky S. Y., Levitsky D. I., and Tsaturyan A. K. The effects of cardiomyopathy-associated mutations in the head-to-tail overlap junction of α-tropomyosin on its properties and interaction with actin. Int. J. Biol. Macromol., 12, 1266–1274 (2019). DOI: 10.1016/j.ijbiomac.2018.09.105
14. 14. Mirza M., Robinson P., Kremneva E., Copeland O., Nikolaeva O., Watkins H., Levitsky D., Redwood C., ElMezgueldi M., and Marston S. The effect of mutations in α-tropomyosin (E40K and E54K) that cause familial dilated cardiomyopathy on the regulatory mechanism of cardiac muscle thin filaments. J. Biol. Chem., 282, 13487–13497 (2007). DOI: 10.1074/jbc.M701071200
15. 15. Van de Meerakker J. B., Christiaans I., Barnett P., Lekanne Deprez R. H., Ilgun A., Mook O. R., Mannens M. M., Lam J., Wilde A. A., Moorman A. F., and Postma A. V. A novel alpha-tropomyosin mutation associates with dilated and non-compaction cardiomyopathy and diminishes actin binding. Biochim. Biophys. Acta, 1833, 833–839 (2013). DOI: 10.1016/j.bbamcr.2012.11.003
16. 16. Colpan M., Ly T., Grover S., Tolkatchev D., and Kostyukova A. S. The cardiomyopathy-associated K15N mutation in tropomyosin alters actin filament pointed end dynamics. Arch. Biochem. Biophys., 630, 18–26 (2017). DOI: 10.1016/j.abb.2017.07.006
17. 17. Lakdawala N. K., Dellefave L., Redwood C. S., Sparks E., Cirino A. L., Depalma S., Colan S. D., Funke B., Zimmerman R. S., Robinson P., Watkins H., Seidman C. E., Seidman J. G., McNally E. M., and Ho C. Y. Familial dilated cardiomyopathy caused by an alpha-tropomyosin mutation: the distinctive natural history of sarcomeric dilated cardiomyopathy. J. Am. Coll. Cardiol., 55 (4), 320–329 (2010). DOI: 10.1016/j.jacc.2009.11.017
18. 18. Barrick S. K., Garg A., Greenberg L., Zhang S., Lin C.-Y., Stitziel N. O., and Greenberg M. J. Functional assays reveal the pathogenic mechanism of a de novo tropomyosin variant identified in patient with dilated cardiomyopathy. J. Mol. Cell. Cardiol., 176, 58–67 (2023). DOI: 10.1016/j.yjmcc.2023.01.014
19. 19. Tsaturyan A. K., Zaklyazminskaya E. V., Polyak M. E., Kopylova G. V., Shchepkin D. V., Kochurova A. M., Gonchar A. D., Kleymenov S. Y., Koubasova N. A., Bershitsky S. Y., Matyushenko A. M., and Levitsky D. I. De novo Asp219Val mutation in cardiac tropomyosin associated with hypertrophic cardiomyopathy. Int. J. Mol. Sci., 24 (1), 18 (2023). DOI: 10.3390/ijms24010018
20. 20. Matyushenko A. M., Nefedova V. V., Kochurova A. M., Kopylova G. V., Koubassova N. A., Shestak A. G., Yampolskaya D. S., Shchepkin D. V., Kleymenov S. Y., Ryabkova N. S., Katrukha I. A., Bershitsky S. Y., Zaklyazminskaya E. V., Tsaturyan A. K., and Levitsky D. I. Novel mutation Glu98Lys in cardiac tropomyosin alters its structure and impairs myocardial relaxation. Int. J. Mol. Sci., 24, 12359 (2023). DOI: 10.3390/ijms241512359
21. 21. Monteiro P. B., Lataro R. C., Ferro J. A., and Reinach F. D. C. Functional α-tropomyosin produced in Escherichia coli. A dipeptide extension can substitute the amino-terminal acetyl group. J. Biol. Chem., 269, 10461–10466 (1994).
22. 22. Pardee J. D. and Spudich J. A. Purification of muscle actin. Methods Enzymol., 85 (Pt B), 164–179 (1982). DOI: 10.1016/0076-687985020-9
23. 23. Matyushenko A. M., Artemova N. V., Sluchanko N. N., and Levitsky D. I. Effects of two stabilizing substitutions, D137L and G126R, in the middle part of α-tropomyosin on the domain structure of its molecule. Biophys. Chem., 196, 77–85 (2015). DOI: 10.1016/j.bpc.2014.10.001
24. 24. Nefedova V. V., Koubassova N. A., Borzova V. A., Kleymenov S. Y., Tsaturyan, A. K., Matyushenko A. M., and Levitsky D. I. Tropomyosin pseudo-phosphorylation can rescue the effects of cardiomyopathy-associated mutations. Int. J. Biol. Macromol., 166, 424–434 (2021). DOI: 10.1016/j.ijbiomac.2020.10.201
25. 25. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680–685 (1970).
26. 26. Nefedova V. V., Kopylova G. V., Shchepkin D. V., Kochurova A. M., Kechko O. I., Borzova V. A., Ryabkova N. S., Katrukha I. A., Mitkevich V. A., Bershitsky S. Y., Matyushenko A. M., and Levitsky D. I. Impact of troponin in cardiomyopathy development caused by mutations in tropomyosin. Int. J. Mol. Sci., 23, 15723 (2022). DOI: 10.3390/ijms232415723